ArticleAnnals of surgical oncology2024

Pretreatment Pan-Immune-Inflammation Value (PIV) in Predicting Therapeutic Response and Clinical Outcomes of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma.

Jifeng Feng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.